Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1983-4-15
|
pubmed:abstractText |
Fifteen patients with gram-negative bacterial toe web infections were treated for 1 week with intramuscular cefoperazone, a broad-spectrum third generation cephalosporin. Initial bacterial cultures in eleven patients (73%) grew more than one gram-negative organism. Pseudomonas aeruginosa was the most frequent isolate. All bacteria isolated were sensitive to cefoperazone (Cefobid). Swelling, redness, and flow of exudate resolved within 1 week of antibiotic administration. By day 7 there was no evidence of inflammation, and denuded areas had begun to re-epithelialize. Side effects were mild and did not require cessation of therapy. This antibiotic causes rapid resolution of a disease which previously required prolonged hospitalizations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0190-9622
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
225-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6219139-Adult,
pubmed-meshheading:6219139-Aged,
pubmed-meshheading:6219139-Bacterial Infections,
pubmed-meshheading:6219139-Cefoperazone,
pubmed-meshheading:6219139-Cephalosporins,
pubmed-meshheading:6219139-Enterobacteriaceae Infections,
pubmed-meshheading:6219139-Foot Dermatoses,
pubmed-meshheading:6219139-Humans,
pubmed-meshheading:6219139-Male,
pubmed-meshheading:6219139-Middle Aged,
pubmed-meshheading:6219139-Proteus Infections,
pubmed-meshheading:6219139-Pseudomonas Infections,
pubmed-meshheading:6219139-Skin Diseases, Infectious,
pubmed-meshheading:6219139-Streptococcal Infections,
pubmed-meshheading:6219139-Toes
|
pubmed:year |
1983
|
pubmed:articleTitle |
Gram-negative bacterial toe web infection: successful treatment with a new third generation cephalosporin.
|
pubmed:publicationType |
Journal Article
|